PPT-Report of Proactive Disclosure Subcommittee

Meeting of the FOIA Advisory Committee Washington DC January 27 2015 We are working on two topics Analyzing FOIA requests to identify highvalue types of records for proactive disclosure Reconciling proactive disclosure with accessibility under Section 508. May 21, 2012 – Call 1 of 2. Sponsoring Offices:. National Center for Ethics in Health Care . Office of Quality, Safety and Value, Risk Management Program. Welcome. Materials from this call as well as the call from August 6, 2012 (Critical Thinking About Institutional Disclosure of Adverse Events to Patients) are available on these websites:. or subcommittee. c. In the event of a question about whether someone is eligible to serve on a P&A Senate committee or subcommittee, the decision will be made by the P&A Consulta . All committees of As of 9/30/2011. IEA Political Action Committee (PAC). Funded By $20 Annual Contributions From. All IEA Members. Governed by Committee Composed of IEA Leaders. Purposes. Elect Pro-Education State Candidates. The devil is in the details!. klgates.com. 2. Background. Securities Exchange Commission (SEC) generally (historically) regulated the issuance of corporate (not public) securities. In the 1990s, embarked on a new venture. Melanie Ann Pustay. Director, Office of Information Policy . Department . of . Justice. 1. 2. July 4, 1966: . President Lyndon Johnson signs into law the Freedom of Information Act (FOIA).. FOIA provides . Douglas Brock, PhD. Alicia Quella, PhD, MPAS, PA-C. Nobody is perfect . . .. . Objectives. Understand that error is common and difficult to reduce in healthcare settings.. Describe a . training exercise to . Guidelines. Presenting . Authors must fully disclose to ARVO and the session participants all commercial relationships relevant to the subject matter for all authors of the presentation and their spouse or partner for the prior 24 months. . Program. Written in Response to Dr. William Brinkman’s charge letter to FESAC of. April 13, . 2012. Presented to FESAC on January 31, 2013. . Riccardo . Betti. , Michael Brown, Vincent Chan, Bruce I. Cohen, Steve Cowley, . Transparency and Participation in the Application of Safeguard . Policies. Presenter: Johnson Appavoo. Presentation prepared by: Agi Kiss. WB Policy on Disclosure of Information 2002. *. . Information Available:. Guevarra. & . Mónica. Reynoso. Goals. Provide an overview of the development of Proactive Registration. Highlight the processes entailed in the collaborative effort. Demonstrate the institutional impact of this successful effort . Proactive vs. Reactive. Calm, cool, and collected. Exploding from pressure. Reactive people. Reactive people make choices . based on impulse.. Impulse is under . the control of emotions. .. Emotions. Russell Dorsey, . CP. h. T. Special Projects/Indigent . C. are . P. rogram . C. oordinator. Baptist Health . M. edical . C. enter – Little Rock. Disclosure. I have no financial interests or other disclosures of conflict of interests for this presentation.. Russell Dorsey, . CP. h. T. Special Projects/Indigent . C. are . P. rogram . C. oordinator. Baptist Health . M. edical . C. enter – Little Rock. Disclosure. I have no financial interests or other disclosures of conflict of interests for this presentation.. Investigator of Record – Definition. “The individual at the CRS responsible for ensuring that a clinical trial is conducted in accordance with the protocol, applicable U.S. federal regulations, in-country regulations and any provisions imposed by the reviewing IRB/EC/other regulatory entity. This person is the signatory for the Form FDA 1572 for studies conducted under an IND or the DAIDS Investigator of Record Form for non-IND studies.” (from DAIDS Protocol Registration Manual, p.8).